Thymosin Alpha-1
Symbol Ta · MW 3108 Da
Thymic peptide that modulates innate and adaptive immunity.
- Discovered
- 1977
- Half-life
- 2 hours
- Approval
- Not FDA-approved in U.S.
Reported effects
- Immune modulation
- Antiviral support
- T-cell function
Overview
Thymosin Alpha-1 is an immune-support peptide that helps regulate immune system activity, especially T-cell function and immune coordination. It was originally isolated from thymic tissue and has been studied for infections, immune dysfunction, and immune recovery. Unlike peptides focused on fat loss or muscle repair, Thymosin Alpha-1 is best known for immune modulation. Its purpose is to support immune balance, improve immune communication, and help the body respond more effectively to immune stress. As a recovery peptide, it is commonly associated with immune resilience, post-illness recovery, and overall immune system support.
How it's taken
- Typical Administration
- Injectable
- Typical Dosage
- Common clinical/research range: 1.6 mg per dose; broader research ranges vary
- Typical Frequency
- Twice weekly is common; some protocols use more frequent dosing
Research sources
Source links included from peer-reviewed literature and trusted medical journal records for this peptide.
Interested in Thymosin Alpha-1?
Enter your email and we'll send you a curated list of vendors we trust for sourcing this peptide.
No spam · Unsubscribe anytime
For educational purposes only. Many peptides shown are research compounds and not approved for human use in all jurisdictions.